Geode Capital Management LLC Lowers Holdings in Astrana Health, Inc. $ASTH

Geode Capital Management LLC reduced its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 1.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,053,336 shares of the company’s stock after selling 13,805 shares during the period. Geode Capital Management LLC owned approximately 1.88% of Astrana Health worth $26,210,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Jacobs Levy Equity Management Inc. boosted its stake in Astrana Health by 211.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company’s stock valued at $7,378,000 after buying an additional 161,580 shares during the period. Hussman Strategic Advisors Inc. raised its holdings in shares of Astrana Health by 50.0% in the 2nd quarter. Hussman Strategic Advisors Inc. now owns 126,000 shares of the company’s stock valued at $3,135,000 after acquiring an additional 42,000 shares in the last quarter. Strs Ohio purchased a new stake in shares of Astrana Health in the 1st quarter valued at about $332,000. First Citizens Bank & Trust Co. bought a new stake in shares of Astrana Health during the 2nd quarter valued at about $301,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Astrana Health by 6.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock worth $15,490,000 after purchasing an additional 28,200 shares in the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Price Performance

ASTH stock opened at $23.10 on Friday. The firm has a market cap of $1.30 billion, a P/E ratio of 45.29, a P/E/G ratio of 0.90 and a beta of 0.80. The firm’s fifty day moving average is $28.16 and its 200 day moving average is $27.00. Astrana Health, Inc. has a 52 week low of $20.12 and a 52 week high of $45.16. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share (EPS) for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The business had revenue of $317.00 million during the quarter. Research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ASTH. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research note on Monday. Jefferies Financial Group reissued a “buy” rating on shares of Astrana Health in a report on Tuesday. BTIG Research dropped their price objective on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a report on Friday, November 7th. TD Cowen reduced their target price on Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a research note on Monday, November 10th. Finally, Barclays dropped their price target on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday. Seven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $43.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.